Global hub for cancer research and treatment.
Hulley & Kirkwood are delighted to be involved with the new ICR Centre for Cancer Drug Discovery – a global hub for cancer research and treatment based in South London.
Architects Feilden+Mawson have developed a Masterplan for 20,400m2 of class B1 (b) accommodation on a 2.5Ha site, on adjoining land to the North of the ICR's Sutton campus, which has achieved planning approval.
The development is designed to make a positive contribution to Medical Research and Development status of the site, allow for phased development to meet funding and minimise disruption and impact on the surrounding area.
An active landscape management plan was developed to protect views and encourage ecological enhancement and promote biodiversity. Orientation of the buildings was considered with the landscape strategy in order to minimise overlooking and long term screening of the site that enhances the outdoor amenity.
The new facility aims to accelerate the discovery of new treatments and will bring together 10,000 scientists, clinical and support staff. New buildings will integrate research, development and cancer care and will encourage collaborative working with the provision of laboratories and clinical facilities to allow for close interaction between scientists and physicians. Development space for biotech, pharma and software companies and equipment manufacturers will also be provided.